Ortho-Clinical Diagnostics

What Ortho-Clinical Diagnostics does

Ortho-Clinical Diagnostics operates as QuidelOrtho Corporation (Nasdaq: OCDX), an in vitro diagnostics company formed by the May 2022 merger of Quidel Corporation and Ortho Clinical Diagnostics (originally part of Johnson & Johnson, founded 1939). The company is headquartered in San Diego, California, with 1,001–5,000 employees, and serves laboratory professionals, healthcare providers, and consumers across 140+ countries and territories. Its core technology spans clinical chemistry and immunoassay systems (VITROS, SOFIA), immunohematology/blood bank analyzers (ORTHO VISION Swift, ORTHO Workstation, ORTHO OPTIX Reader, ORTHO Summit), molecular diagnostic platforms (LYRA real-time PCR assays, SOLANA, SAVANNA, VIRENA), and point-of-care rapid tests (QUICKVUE, TRIAGE). Supporting offerings include ORTHO CONNECT lab management software, QuidelOrthoCQ quality control, and VALUMETRIX lab consulting services, with a portfolio of more than 550 assays.

The company operates a dual revenue model: hardware/equipment sales of diagnostic instrument systems and point-of-care devices, paired with high-margin recurring revenue from proprietary assays, reagents, and consumables consumed on its installed base. It goes to market primarily through an enterprise field sales organization targeting hospital laboratories, reference laboratories, blood banks, and healthcare providers, complemented by the Ortho Plus customer portal for ordering and support and a retail/consumer channel for at-home QUICKVUE COVID-19 tests. Strategic initiatives include the 2026 acquisition of Lex Diagnostics (adding the Nulexa System), the Allo Hope Foundation partnership for alloimmunized pregnancy testing, and ongoing geographic localization across Europe, MEA, APAC, and the Americas.

Name

Ortho-Clinical Diagnostics

Legal name

QuidelOrtho Corporation

Website

https://orthoclinical.com

Company type

Public

Founded year

2022

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

QuidelOrtho (operating as Ortho-Clinical Diagnostics, Nasdaq: OCDX) is an in vitro diagnostics company offering 550+ assays across clinical chemistry, immunoassay, immunohematology, molecular diagnostics, and point-of-care testing, serving hospital laboratories, reference labs, blood banks, healthcare providers, and consumers in 140+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical Chemistry & Immunoassay Systems (HLAHAAAA)

akta.pro secondary industries

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• In vitro diagnostics
• Clinical chemistry analyzers
• Immunohematology testing
• Molecular diagnostic assays
• Point-of-care testing

Headquarters

HQ city

Raritan

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Instruments and Systems: Sale of diagnostic instrument systems including VITROS systems, SOFIA analyzers, ORTHO VISION systems, and related equipment
2. Assays and Reagents: Recurring revenue from sale of assay tests and reagents consumables used on their instrument platforms across clinical chemistry, immunoassay, immunohematology and molecular diagnostics
3. Point-of-Care Testing Products: Sale of rapid diagnostic tests including QUICKVUE lateral-flow tests for consumer and professional use
4. Immunohematology Solutions: Blood bank testing solutions including ORTHO Workstation, ORTHO OPTIX Reader for transfusion medicine

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Ortho-Clinical Diagnostics (QuidelOrtho) manufactures and sells in vitro diagnostic instruments, reagents and assays used by hospital laboratories, reference labs, blood banks, clinics and pharmacies to perform clinical chemistry, immunoassay, immunohematology, molecular, and point-of-care diagnostic testing. Its offering combines proprietary analyzer platforms (VITROS, SOFIA, ORTHO VISION Swift, ORTHO Workstation/Summit, SAVANNA, SOLANA, TRIAGE) with a recurring consumable menu of more than 550 assays, plus rapid lateral-flow tests such as QUICKVUE and an at-home COVID-19 antigen test sold through retail.

Product overview

QuidelOrtho (operating as Ortho Clinical Diagnostics, Nasdaq: OCDX) offers a comprehensive in vitro diagnostics portfolio spanning clinical chemistry, immunoassay, molecular diagnostics, immunohematology, and point-of-care testing. The core platform consists of VITROS Systems for automated chemistry and immunoassay testing, supported by the SOFIA Platform for rapid benchtop diagnostics, ORTHO VISION Swift and ORTHO Workstation for immunohematology/blood bank testing, and molecular platforms including SAVANNA, SOLANA, and LYRA assays for real-time PCR. The portfolio includes over 550 assays offered across 140+ countries, featuring products like QUICKVUE rapid tests (including COVID-19), TRIAGE point-of-care systems, and specialized tests for thyroid function, bone health, and autoimmune conditions. The company also provides supporting solutions including ORTHO CONNECT lab management software, VITROS Automation Solutions for workflow integration, and quality control products like QuidelOrthoCQ and VALUMETRIX consulting services.

Differentiator

Problem solved

Functional benefit

Brands

• VITROS: VITROS Systems for clinical chemistry and immunoassay testing
• QUICKVUE
• SOFIA
• ORTHO VISION
• ORTHO OPTIX
• LYRA
• TRIAGE
• SAVANNA
• SOLANA
• VIRENA
• MICROVUE
• ORTHO CONNECT
• QuidelOrthoCQ
• VALUMETRIX
• ELVIS
• D3

Products and services

• VITROS Systems Automated clinical chemistry and immunoassay analyzer systems that deliver fast, accurate, and reliable diagnostic results for hospital, reference and clinical laboratories of every size.
• SOFIA Platform Benchtop diagnostic testing platform, including the SOFIA 2 Analyzer, designed for rapid immunoassay testing at the point of care for healthcare providers.
• ORTHO VISION Swift Automated Immunohematology System Automated blood-bank analyzer providing enhanced processing power, responsiveness and data security for high-volume immunohematology testing in transfusion medicine labs.
• ORTHO OPTIX Reader Semi-automated blood-bank analyzer that integrates with the ORTHO Workstation to deliver complete immunohematology testing solutions for transfusion laboratories.
• ORTHO Workstation Immunohematology Analyzer Scalable semi-automated immunohematology solution built around proven column agglutination technology for transfusion laboratories.
• ORTHO Summit System High-throughput automated immunohematology system designed for large-scale blood-bank operations.
• LYRA Assays Real-time PCR assays for molecular testing, designed as an open-platform solution for high-quality molecular diagnostics in laboratories.
• QUICKVUE Rapid Lateral-Flow Tests Rapid lateral-flow diagnostic tests that produce accurate results in minutes, supporting faster diagnoses and improved patient outcomes in point-of-care settings.
• QUICKVUE COVID-19 Test At-home rapid COVID-19 antigen test designed for fast, simple, and easy use by individual consumers and available through retail channels.
• TRIAGE System Point-of-care diagnostic system providing rapid, lab-quality immunoassay results for various clinical conditions in healthcare provider settings.
• SOLANA Molecular Testing Platform Molecular diagnostic testing platform for syndromic infectious disease testing at the point of care.
• SAVANNA Platform Multi-assay molecular diagnostic platform for rapid infectious disease detection.
• VIRENA System Molecular diagnostic system for infectious disease testing and surveillance.
• ORTHO CONNECT Lab Management Software Laboratory management software solution for data integration and workflow optimization across the company's diagnostic instrument portfolio.
• MICROVUE Products Immunoassay products for diagnostic applications including autoimmune testing and complement protein measurement.
• THYRETAIN Thyroid BioAssays Thyroid function diagnostic bioassays for clinical use.
• INFLAMMADRY MMP-9 Test Point-of-care test for detecting Matrix Metalloproteinase-9, used in inflammatory condition assessment.
• D3 Products - Virus Testing Solutions Virus testing solutions for diagnostic applications.
• ELVIS HSV Test System Herpes simplex virus diagnostic test system using direct fluorescent antibody technology.
• CUSTOMCELLS Custom cell products for diagnostic and research applications.
• READYCELLS Rapid Culture System Rapid cell culture system for accelerated diagnostic results.
• VALUMETRIX Lab Consulting Services Laboratory consulting services that help customers optimize diagnostic lab operations, workflow and efficiency.
• QuidelOrthoCQ Quality control products and program for diagnostic testing across the QuidelOrtho portfolio.
• Nulexa System Diagnostic system acquired from Lex Diagnostics in 2026 that expands QuidelOrtho's in vitro diagnostics product portfolio.

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Two partnerships are on record, tiered core.

• Allo Hope FoundationcoreStrategic or Co-development Partner · 2 June 2026QuidelOrtho and Allo Hope Foundation joined forces to advance education, connection, and early testing for alloimmunized pregnancies. The partnership focuses on improving awareness and testing for blood compatibility issues during pregnancy to prevent complications from alloimmunization.
• Allo Hope FoundationcoreGTM or Marketing PartnerCollaboration to improve education and early testing awareness for alloimmunized pregnancies, demonstrating commitment to women's health and pregnancy care diagnostics.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Roche Diagnostics: Global IVD leader with cobas clinical chemistry/immunoassay, blood screening, and molecular platforms that compete head-on with VITROS across hospital and reference lab channels.
• Abbott Diagnostics: Operates ARCHITECT clinical chemistry/immunoassay, Alinity, and rapid point-of-care diagnostics, providing overlapping menu and global reach comparable to QuidelOrtho.
• Siemens Healthineers: Atellica and ADVIA Centaur chemistry/immunoassay systems plus an immunohematology and molecular portfolio that directly competes with VITROS and ORTHO VISION in hospital core labs.
• Beckman Coulter Diagnostics (Danaher): DxH/AU clinical chemistry, Access immunoassay, and DxI automation compete directly with VITROS for high-throughput lab share and against QuidelOrtho's automation solutions.
• Thermo Fisher Scientific (Diagnostics): Operates a broad IVD and specialty diagnostics portfolio including immunoassays and clinical chemistry reagents, overlapping with multiple QuidelOrtho product lines globally.

Direct peers

• bioMérieux: VITEK and VIDAS clinical chemistry/immunoassay plus industrial microbiology overlap with QuidelOrtho's clinical diagnostic and infectious disease testing franchises.
• Hologic: Panther molecular diagnostics platform and Aptima assays overlap directly with QuidelOrtho's SOLANA, SAVANNA, and LYRA molecular test menus in hospital labs.
• Becton Dickinson (BD): BD MAX and BD Veritor molecular/rapid diagnostics plus MaxCollection lab supplies overlap with QuidelOrtho's molecular and point-of-care offerings.
• Bio-Rad Laboratories: Provides clinical chemistry, immunoassay, and quality controls (Unity) that closely parallel VITROS QC Solutions and QuidelOrthoCQ offerings for hospital and reference labs.
• Sysmex: Leading hematology and hemostasis vendor with growing clinical chemistry ambitions; competes with QuidelOrtho in blood bank/immunohematology workflow instruments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/OrthoClinicalDX
• YouTubeyoutube.com/channel/UCWH7q_2wI_25OjHS3fcci8g
• Facebookfacebook.com/QuidelOrtho
• LinkedInlinkedin.com/company/quidelortho
• Instagraminstagram.com/QuidelOrtho

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ortho-Clinical Diagnostics